Choosing treatment for proliferative lupus nephritis.
Balow
James E
JE
D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy* / Q000208:ethnology / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy* / Q000208:ethnology / Q000209:etiology; D011364:Professional Practice; D044469:Racial Groups; D012219:Rheumatology / Q000379:methods*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide